Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial – TheStreet.com
TheStreet.com |
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com More patients with amyotrophic lateral sclerosis (ALS) had a positive response to an injection of an experimental stem cell therapy developed by Brainstorm Cell Therapeutics (BCLI) compared to similar ALS patients given a placebo, according to results … Brainstorm's Cell Therapy Succeeds In ALS Mid-Stage Study Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) Is About To Release Clinical Study Results Shares of Brainstorm Cell Therapeutics (BCLI) Rally 17.26% |
